June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
ZIKA virus efficiently replicates in human retinal pigment epithelium and disturbs its permeability
Author Affiliations & Notes
  • Vasiliki Kalatzis
    Inserm U1051, Montpellier, France
  • Nejla Erkilic
    Inserm U1051, Montpellier, France
  • Krishna Damodar
    Inserm U1051, Montpellier, France
  • Jean-Pierre Molès
    Inserm UMR1058, Montpellier, France
  • Chantal Fourrier-Wirth
    Etablissement Francais du Sang, Montpellier, France
  • Nicolas Nagot
    Inserm UMR1058, Montpellier, France
  • Philippe Van de Perre
    Inserm UMR1058, Montpellier, France
  • Yannick Simonin
    Inserm UMR1058, Montpellier, France
  • Sara Salinas
    Inserm UMR1058, Montpellier, France
  • Footnotes
    Commercial Relationships   Vasiliki Kalatzis, None; Nejla Erkilic, None; Krishna Damodar, None; Jean-Pierre Molès, None; Chantal Fourrier-Wirth, None; Nicolas Nagot, None; Philippe Van de Perre, None; Yannick Simonin, None; Sara Salinas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3629. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Vasiliki Kalatzis, Nejla Erkilic, Krishna Damodar, Jean-Pierre Molès, Chantal Fourrier-Wirth, Nicolas Nagot, Philippe Van de Perre, Yannick Simonin, Sara Salinas; ZIKA virus efficiently replicates in human retinal pigment epithelium and disturbs its permeability. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3629.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recently, the Flavivirus Zika virus (ZIKV) has rapidly spread in the Americas and in the Caribbean islands. While a large proportion of infected persons are subjected to mild or asymptomatic disease, neurological disorders such as Guillain-Barré syndrome and microcephaly have been linked to ZIKV infections. Notably, ZIKV-associated cerebral malformations can be associated with ocular disorders and ZIKV is found in the eye anterior chamber fluid and in conjunctival swab samples of patients. Moreover, ZIKV-infected mice develop ocular disorders and viral RNA is detected in the retina, optic nerve, tears and lacrimal glands.

Methods : We, and others, have shown that the human induced pluripotent stem cell (iPSc)-derived retinal pigment epithelium (RPE) is morphologically and functionally characteristic of the RPE in vivo. It thus represents a powerful model for studying pathophysiology of the RPE, a tissue normally inaccessible for experimental manipulation. To study ZIKV ability to replicate in the human retina, we infected confluent iPSc-derived RPE with a clinical Asian lineage ZIKV isolated in French Polynesia (H/PF/2013).

Results : We showed that ZIKV efficiently replicated in the iPSc-derived RPE. Four days post-infection (p.i.), a diffuse viral labeling was seen inside the cells. Interestingly, by 11 days p.i., the location of the intracellular virions changed to a close proximity to the cellular membrane. This coincided with a less marked ZO-1 labelling of the infected RPE compared to controls, suggesting that integrity of the cell layer could be impaired. We measured the transepithelial resistance (TER) of the RPE monolayers and showed a perturbation of the TER from 7 days p.i., consistent with an alteration of epithelium permeability. Finally, electron microscopy analyses showed an impairment of cell junctions after ZIKV infection.

Conclusions : Our data underline the potential permissibility of human RPE to ZIKV infection and the associated deleterious effect on permeability. Our work also draws attention to the necessity of better investigating the ocular disorders associated in ZIKV-infected patients and to evaluate the risk of transmission by eye. Lastly, it provides a further and novel example of the use of iPSc-derived retinal cells for evaluating pathophysiology.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×